PE0116 Injection in Treatment of Patients With Advanced Solid Tumours

NCT05800249 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced/Metastatic Solid Tumors

Interventions

DRUG: PE0116

Sponsor

Shanghai HyaMab Biotech Co.,Ltd.